- Home
- DELL vs BMY Comparison
DELL vs BMY Comparison
Compare DELL & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DELL
- BMY
- Stock Information
- Founded
- DELL 1984
- BMY 1887
- Country
- DELL United States
- BMY United States
- Employees
- DELL N/A
- BMY N/A
- Industry
- DELL Computer Manufacturing
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- DELL Technology
- BMY Health Care
- Exchange
- DELL Nasdaq
- BMY Nasdaq
- Market Cap
- DELL 88.5B
- BMY 94.0B
- IPO Year
- DELL 1988
- BMY N/A
- Fundamental
- Price
- DELL $150.59
- BMY $44.57
- Analyst Decision
- DELL Strong Buy
- BMY Hold
- Analyst Count
- DELL 16
- BMY 15
- Target Price
- DELL $151.73
- BMY $57.64
- AVG Volume (30 Days)
- DELL 7.5M
- BMY 18.1M
- Earning Date
- DELL 11-25-2025
- BMY 10-30-2025
- Dividend Yield
- DELL 1.39%
- BMY 5.55%
- EPS Growth
- DELL 18.71
- BMY N/A
- EPS
- DELL 6.87
- BMY 2.49
- Revenue
- DELL $101,451,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- DELL $14.94
- BMY N/A
- Revenue Next Year
- DELL $7.81
- BMY N/A
- P/E Ratio
- DELL $21.96
- BMY $17.96
- Revenue Growth
- DELL 10.47
- BMY 2.57
- 52 Week Low
- DELL $66.25
- BMY $42.96
- 52 Week High
- DELL $154.70
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- DELL 67.67
- BMY 43.00
- Support Level
- DELL $140.41
- BMY $44.66
- Resistance Level
- DELL $152.10
- BMY $48.58
- Average True Range (ATR)
- DELL 5.42
- BMY 1.19
- MACD
- DELL 1.85
- BMY 0.05
- Stochastic Oscillator
- DELL 87.02
- BMY 25.88
About DELL Dell Technologies Inc.
Dell Technologies is a broad information technology vendor, primarily supplying hardware to enterprises. It is focused on premium and commercial personal computers and enterprise on-premises data center hardware. It holds top-three market shares in its core markets of personal computers, peripheral displays, mainstream servers, and external storage. Dell has a robust ecosystem of component and assembly partners, and also relies heavily on channel partners to fulfill its sales.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.